Although the CRO industry has existed for decades, it is now evolving faster than ever as competition rises between organizations and the demand for outsourced clinical services is increasing. As the drug development process is becoming more and more complex, the pharmaceutical industry leverages all the opportunities to make the process more efficient.
Contract Research Organizations, or CROs, provide services for industries (pharmaceutical, medical device and biotechnology) who want to outsource operations. Among the services these organizations offer are project management, data entry and validation, data management of clinical trials, medicine and disease coding and much more, up to final study reports.
According to The Business Company Research, outsourcing to CROs is expected to grow at a CAGR (Compound Annual Growth Rate) of 7.4% by the end of 2019. The market is estimated to grow till 2021 and have a value of $44.4 billion. As stated in the study by Grand View Research Inc., the CRO market will reach $54.7 billion by the year 2025.
Although CROs outsource services for multiple industries, according to the estimation of the Association of Clinical Research Organizations, half of the CROs outsource services for the pharmaceutical industry.
CROs provide support in clinical research and trials, commercialization of products, pharmacovigilance, etc. Some organizations take care of almost all procedures, starting from clinical trials up to the approval of FDA (USA) and EMA (Europe) or other regional authorities that are in charge of approving drug products.
There are large CROs, which provide services internationally, relatively smaller organizations and niche-specific CROs.
CROs work as third-parties for clients that are called sponsors. Notwithstanding the fact that sponsors ‘hire’ contract research organizations to conduct researches, trials, etc., they are still the ones responsible for the factuality of data and how much it is backed by science. The budget is controlled by the sponsor and the planning is upon the CRO.
Because CROs performs so many functions and carry out so many procedures, the CRO team is naturally quite big and with multiple departments:
Drug development is a complex process that needs a lot of attention and resources. This is why it is quite wise to transfer the tasks related to drug development or clinical trials to a third-party CRO. Here are what benefits you can reap when working with a CRO:
Contract Research Organizations bring numerous benefits to the pharmaceutical, biotech and healthcare industries. With reduced costs, companies and organizations get a final product, the quality of which is higher than it would have been if the processes were not outsourced.
Back to Insights